BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
4 hedge funds and large institutions have $1.22M invested in BriaCell Therapeutics Corp Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
0.86% less ownership
Funds ownership: 4.05% → 3.19% (-0.86%)
20% less funds holding
Funds holding: 5 → 4 (-1)
22% less capital invested
Capital invested by funds: $1.57M → $1.22M (-$350K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $445K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$354 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$172K |
| 2 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$159K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $926K | – | – | – |
|
|
RAM
2
Redmond Asset Management
Henrico,
Virginia
| $180K | – | – | – |
|
|
SFA
3
Sequoia Financial Advisors
Akron,
Ohio
| $111K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $351 | +$354 | +142 | New |
|
|
KJHP
5
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| – | -$172K | -68,885 | Closed |
|
|
PFM
6
Privium Fund Management
Amsterdam,
Netherlands
| – | -$159K | -64,907 | Closed |
|
BCTXW Hedge Fund Activity: Q3 2023 in Review
4 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q3 2023, worth a combined $1.22M — down 22% from $1.57M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BCTXW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $354. The largest seller was K.J. Harrison & Partners, exiting entirely with an estimated $172K sold.
- 4 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q3 2023, down from 5 in Q2 2023.
- Funds reported $1.22M of BriaCell Therapeutics Corp Warrant stock for Q3 2023, down 22% quarter-over-quarter.
- 1 fund opened new BriaCell Therapeutics Corp Warrant positions in Q3 2023 and 2 closed out, a net change of -1 holder.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q3 2023 was UBS Group, an estimated $354 added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q3 2023 was K.J. Harrison & Partners, an estimated $172K sold.
Based on aggregated 13F filings for Q3 2023.